Roivant Sciences Ltd. entered into an underwriting agreement with Goldman Sachs & Co. LLC, SVB Securities LLC, Cowen and Company, LLC and Cantor Fitzgerald & Co. for an underwritten offering of 30,666,665 common shares at an offering price of $7.50 per share, resulting in gross proceeds of approximately $230 million.